title: Conventional dose cytosine arabinoside in combination chemotherapy for acute myelogenous leukemia.
authors.forename: T A
authors.initials: TA
authors.lastname: Lister
authors.forename: A Z
authors.initials: AZ
authors.lastname: Rohatiner
authors.forename: R
authors.initials: R
authors.lastname: Bassan
authors.forename: W
authors.initials: W
authors.lastname: Gregory
authors.forename: L
authors.initials: L
authors.lastname: Willis
authors.forename: M J
authors.initials: MJ
authors.lastname: Barnett
authors.forename: J
authors.initials: J
authors.lastname: Waxman
authors.forename: M A
authors.initials: MA
authors.lastname: Richards
authors.forename: T S
authors.initials: TS
authors.lastname: Ganesan
authors.forename: J
authors.initials: J
authors.lastname: Tucker
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008875:Middle Aged; D013997:Time Factors
chemical_list: D003561:Cytarabine; D004317:Doxorubicin